Duke Alumnus Receives Marshall Scholarship for Graduate Study in the United Kingdom
Currently at the National Institutes of Health, Glasstetter is working to discover new small-
molecule therapeutics for two protein-misfolding diseases: Parkinson’s disease, a common neurodegenerative disease, and Gaucher disease, a rare lysosomal storage disorder.
“Logan is an exceptional student and scientist who distinguished himself through his undergraduate research in two Duke faculty labs, and is motivated to pursue a career in medical science for the benefit of others,” said Duke President Vincent E. Price. “I am delighted he has been selected as a Marshall Scholar and will have the opportunity to continue his studies in the United Kingdom.”
As a Marshall Scholar, Glasstetter will pursue a master’s degree in drug discovery and development at the University of Leeds and a master’s in chemistry at the University of Cambridge.
He plans to become a physician-scientist in the field of drug discovery and development, producing novel therapies for difficult-to-treat protein-misfolding diseases. In the UK, he plans to study these diseases, which include Parkinson’s disease, Alzheimer’s disease, and Type 2 diabetes, by training under internationally renowned experts focusing on structure-based drug discovery.
Duke students and alumni can receive support for opportunities like the Marshall Scholarship from the Nationally Competitive Scholarships team at the Office of University Scholars and Fellows.
RELATED STORY